Mace replaces Skanska on £500m Cambridge pharma HQ
AstraZeneca has replaced Skanska with Mace on its Cambridge HQ and pushed back completion of the project to 2020.
AstraZeneca has replaced Skanska with Mace on its Cambridge HQ and pushed back completion of the project to 2020.
The scheme was first unveiled in 2013 with an expectation that the £330m research centre and corporate HQ would be completed by 2016.